Data from a post-hoc analysis of the Phase 3 clinical trial of Stelara® (ustekinumab) for treatment of people with moderate-to-severe lupus further validates the value of the Lupus Foundation of ...

A new Peruvian study finds the Lupus Foundation of America's REAL™ (Rapid Evaluation of Activity in Lupus) clinician-reported outcome (ClinRO) and patient-reported outcome (PRO) effectively help ...

San Jose, Calif.--March 3, 2003--Rapid strides in microelectronics and computers are facilitating the design and development of smart devices such as the Intelligent Device for Energy Expenditure and ...

PALO ALTO, Calif.--(BUSINESS WIRE)--Inscopix, Inc., a leading neurotechnology company in California that empowers breakthroughs in brain science, today announced the publication of the first ...